Atlas Trials

Radioimmunotherapy With 131I-L19SIP in Patients With Cancer

Clinical trial NCT01242943 · TERMINATED

Trial details

NCT number
NCT01242943
Sponsor
Philogen S.p.A.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Patients With Cancer
Start date
2008-11-01
Primary completion
2011-02-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.